BostonGene

BostonGene and NEC Collaborate to Analyze Cancer Patients in Clinical Trials

Integrated Genomic and Transcriptomic Next Generation Sequencing (NGS) Data to Reveal Cellular Content of Tumor Microenvironment Tokyo, July 21, 2020:…

4 years ago

Biomedical Software Startup BostonGene Secures $50M in Series A Financing from NEC

New Delhi, April 26, 2019: NEC Corporation (TSE: 6701) and BostonGene Corporation (BostonGene), a Boston, Mass-based biomedical software company, has…

6 years ago